Evotec SE (EVO) Retained Earnings (2009 - 2026)
Evotec SE's (EVO) quarterly Retained Earnings came in at $1.7 billion in Q2 2026, up 3.46% year-over-year from $1.7 billion in Q2 2025, and little changed quarter-over-quarter from $1.7 billion in Q1 2026.
Analysis
Evotec SE (EVO) Retained Earnings (2009 - 2026) Analysis & Trends
Evotec SE has disclosed Retained Earnings across 9 years of filings, most recently posting $1.7 billion for Q2 2026.
- In Q2 2026, Retained Earnings rose 3.46% year-over-year to $1.7 billion; the TTM figure through Jun 2026 stood at $1.7 billion (up 3.46% YoY), while the FY2025 annual figure was $1.6 billion, up 4.66% from the prior year.
- Retained Earnings came in at $1.7 billion for Q2 2026 at Evotec SE, roughly flat from $1.7 billion in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $1.7 billion in Q1 2026 to a low of $1.4 billion in Q3 2022.
- Average Retained Earnings over 5 years is $1.6 billion, with a median of $1.6 billion recorded in 2024.
- The largest YoY upside for Retained Earnings was 18.7% in 2022 against a maximum downside of 10.2% in 2022.
- Over 5 years, Retained Earnings stood at $1.5 billion in 2022, then climbed by 6.17% to $1.6 billion in 2023, then fell by 0.34% to $1.6 billion in 2024, then advanced by 9.22% to $1.7 billion in 2025, then rose by 0.57% to $1.7 billion in 2026.
- Per Business Quant data, the three most recent Retained Earnings figures were $1.7 billion in Q2 2026, $1.7 billion in Q1 2026, and $1.7 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 7.96 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | -511.37 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 2.30 Bn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 1.37 Bn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 2.14 Bn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | 1.71 Bn |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 6.70 Bn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -81.50 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -106.74 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -357.34 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.71 Bn |
| Mar 31, 2026 | 1.71 Bn |
| Dec 31, 2025 | 1.70 Bn |
| Sep 30, 2025 | 1.71 Bn |
| Jun 30, 2025 | 1.65 Bn |
| Mar 31, 2025 | 1.53 Bn |
| Dec 31, 2024 | 1.55 Bn |
| Sep 30, 2024 | 1.59 Bn |
| Dec 31, 2023 | 1.56 Bn |
| Jun 30, 2023 | 1.57 Bn |
| Dec 31, 2022 | 1.47 Bn |
| Sep 30, 2022 | 1.45 Bn |
| Mar 31, 2022 | 1.61 Bn |
| Dec 31, 2021 | 1.64 Bn |
| Sep 30, 2021 | 1.22 Bn |
| Dec 31, 2020 | 1.23 Bn |
| Sep 30, 2010 | 837.97 Mn |
| Jun 30, 2010 | 827.11 Mn |
| Mar 31, 2010 | 898,018.93 |
| Dec 31, 2009 | 957.54 Mn |